Zentalis Pharmaceuticals Inc ZNTL

NAS: ZNTL | ISIN: US98943L1070 14/11/2024

3,950 USD (+0,77%)

(+0,77%) 14/11/2024

Grafiek Zentalis Pharmaceuticals Inc

Grafiek Zentalis Pharmaceuticals Inc

1 dag1d 0,77%
1 week1w -0,25%
1 maand1m 34,35%
3 maanden3m 23,44%
6 maanden6m -67,01%
1 jaar1j -66,30%
5 jaar5j -82,97%

Zentalis Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

29 december 2022 · Moore Kuehn, PLLC Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm · Persbericht

10 maart 2021 · Zentalis Pharmaceuticals Announces Late-Breaker Oral Presentation on WEE1 Inhibitor, ZN-c3, at the AACR Annual Meeting 2021 · Persbericht

24 februari 2021 · Zentalis Pharmaceuticals to Present Initial Clinical Data on ZN-c3 at the AACR Annual Meeting 2021 · Persbericht

10 februari 2021 · Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors · Persbericht

5 februari 2021 · Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences · Persbericht

Profiel Zentalis Pharmaceuticals Inc

Beleggingstrusts/Mutual Funds

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: zentalis.com

Hoofdzetel: New York, NY Verenigde Staten

CEO: Kimberly Lynn Blackwell

Werknemers: 166

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe